Thanks WAG - appreciate the reply. Yes silly me I had it in my head that Acadia was Rett only, not ALL indications. I assume thus that in the years ahead as 2566 is further developed for other syndromes/rare diseases, this is further incremental upside for NEU but the onus is on Acadia driving this (rather than NEU).
Thanks WAG - appreciate the reply. Yes silly me I had it in my...
-
- There are more pages in this discussion • 8,242 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |